Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone?

Neurology
M WellerJ Dichgans

Abstract

Steroids are commonly administered for the control of edema, mass effect, and side effects from therapy to patients with malignant glioma who are receiving radiotherapy and chemotherapy. Here, we report that therapeutic concentrations of dexamethasone (DEX) attenuate cytotoxicity and growth inhibition of human malignant glioma cells induced by exposure to several chemotherapeutics, including ACNU, VM-26, vincristine, cytarabine, methotrexate, and adriamycin. DEX-mediated cytoprotection is not linked to DEX effects on glioma cell proliferation. However, the cytoprotective effects of DEX appeared to be more prominent in cell lines with wild-type p53 status (n = 2) than in p53 mutant cell lines (n = 3). Further, DEX-mediated rescue from chemotherapy does not directly involve Bcl-2 family proteins since DEX failed to change the expression of Bcl-2 or Bax proteins and since bcl-2 gene transfer-mediated cytoprotection was not redundant with the effects of DEX. DEX thus appears to control a common, bcl-2-independent death pathway in glioma cells that is not limited to specific drug actions. Chemotherapy is usually given as an elective, adjuvant treatment to glioma patients in stable condition who can tolerate steroid withdrawal. To ma...Continue Reading

Citations

Jul 21, 2006·Acta Neuropathologica·Caroline PietteManuel Deprez
Jul 30, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·P C NathanB M Feldman
Apr 25, 2012·Journal of Molecular Neuroscience : MN·Shuguang ZhangLei Shi
Apr 30, 1998·Journal of the Neurological Sciences·L RiegerR Meyermann
Feb 1, 2003·Lancet·Anthony BehinJean-Yves Delattre
Feb 23, 2000·Neuroscience·A M GormanS Ceccatelli
Oct 16, 2001·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·M A AltinozA Sav
Jun 16, 2001·British Journal of Pharmacology·U K MessmerJ Pfeilschifter
Dec 25, 2003·Journal of Clinical Pathology·N NathooM Golubic
May 16, 2006·Apoptosis : an International Journal on Programmed Cell Death·Tríona Ní ChonghaileAfshin Samali
Oct 22, 2010·Current Opinion in Neurology·Patrick RothMichael Weller
Aug 31, 1999·Immunopharmacology and Immunotoxicology·H O PaeH T Chung
Aug 15, 2009·Expert Opinion on Investigational Drugs·Jennifer A MoliternoSusan C Pannullo
Aug 23, 2011·Journal of Pharmaceutical and Biomedical Analysis·Kathleen GerbethMona Abdel-Tawab
Mar 30, 2016·Brain : a Journal of Neurology·Kenneth L PitterDolores Hambardzumyan
Jun 12, 1999·Biochemical and Biophysical Research Communications·A RollerM Weller
Jun 7, 2014·Frontiers in Physiology·Zahra MoinfarPedro M Faustmann
Sep 11, 2016·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Roger Murayi, Prashant Chittiboina
Sep 17, 2016·Neurosurgery·Kenan AlkhaliliJuan C Fernandez-Miranda
Jun 29, 2014·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Kelly DugginBelinda Mandrell
Sep 2, 2017·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Clemens Seidel, Rolf-Dieter Kortmann
Aug 15, 2003·World Journal of Gastroenterology : WJG·Fa-Quan Liu, Ji-Ren Zhang
Dec 8, 1998·International Journal of Cancer. Journal International Du Cancer·M WellerJ Dichgans
Jun 3, 2015·Neuro-oncology Practice·Patrick RothMichael Weller
Mar 15, 2003·The Journal of Biological Chemistry·Duncan M GascoyneMaria d M Vivanco
Jun 14, 2003·The Journal of Biological Chemistry·Deepika RajeshSteven P Howard
Apr 18, 1998·Brain Pathology·M WellerH Ohgaki
Nov 27, 2002·Cancer Investigation·Olivera GrbovicSelma Kanazir
Apr 25, 2007·Journal of Neuro-oncology·Luci BavarescoAna Maria Oliveira Battastini
Sep 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ingo B Runnebaum, Ansgar Brüning

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.